Vol. 51, No. 6, 2017

Molecular Biology

A simultaneous English language translation of this journal is available from Pleiades Publishing, Ltd.
Distributed worldwide by Springer. Molecular Biology ISSN 0026-8933.

Antibody-Based Drugs and Other Recombinant Proteins for Diagnostics and Therapy of Viral Infections, Autoimmune Diseases and Cancer

D. V. Kuprash, F. Yu. Garib and S. A. Nedospasov p. 769 abstract

Engineering Antibodies as Drugs: Principles and Practice

A. A. Lugovskoy p. 772 abstract

Next-Generation Techniques for Discovering Human Monoclonal Antibodies

A. A. Lushova, M. G. Biazrova, A. G. Prilipov, G. K. Sadykova, T. A. Kopylov and A. V. Filatov p. 782 abstract

Targeted Bifunctional Proteins and Hybrid Nanoconstructs for Cancer Diagnostics and Therapies

S. M. Deyev and E. N. Lebedenko p. 788 abstract

In vitro Antiviral Activity of Recombinant Antibodies of IgG and IgA Isotypes to Hemagglutinin of the Influenza A Virus

V. V. Argentova, T. K. Aliev, V. V. Zarubaev, S. A. Klotchenko, A. A. Shtro, M. V. Sergeeva, V. A. Toporova, D. A. Dolgikh, P. G. Sveshnikov, V. A. Vasin and M. P. Kirpichnikov p. 804 abstract

Analysis of the Specificity of IgA Antibodies Produced in the Mouse Small Intestine

N. E. Sharanova, J. Ninnemann, M. A. Bondareva, Y. K. Semin, A. V. Nomokonova and A. A. Kruglov p. 813 abstract

Requirements for the Induction of Broadly Neutralizing Antibodies against HIV-1 by Vaccination

A. N. Vzorov and L. V. Uryvaev p. 819 abstract

Peculiarities of the Mechanism of Interactions of Catalytic Antibodies with Organophosphorus Substrates

Yu. A. Mokrushina, S. O. Pipiya, A. V. Stepanova, O. G. Shamborant, V. D. Knorre, I. V. Smirnov, A. G. Gabibov and I. I. Vorobiev p. 830 abstract

Exceptional Diversity of Catalytic Antibodies with Varying Activity in the Blood of Autoimmune and Viral Disease Patients

V. N. Buneva and G. A. Nevinsky p. 840 abstract

A Method for the Parallel and Sequential Generation of Single-Domain Antibodies for the Proteomic Analysis of Human Blood Plasma

O. S. Goryainova, T. I. Ivanova, M. V. Rutovskaya and S. V. Tillib p. 855 abstract

Bifunctional Toxin DARP-LoPE Based on the Her2-Specific Innovative Module of a Non-Immunoglobulin Scaffold as a Promising Agent for Theranostics

G. M. Proshkina, D. V. Kiseleva, O. N. Shilova, A. V. Ryabova, E. I. Shramova, O. A. Stremovskiy and S. M. Deyev p. 865 abstract

T Lymphocytes with Modified Specificity in the Therapy of Malignant Diseases

A. S. Vdovin, N. A. Bykova and G. A. Efimov p. 874 abstract

Recombinant Monoclonal Antibodies, from Tumor Targeting to Cancer Immunotherapy: A Critical Overview

J.-P. Mach p. 887 abstract

Antibody Engineering: From the Idea to Its Implementation

O. L. Polanovsky p. 900 abstract

Conformational Fingerprinting Using Monoclonal Antibodies (on the Example of Angiotensin I-Converting Enzyme-ACE)

S. M. Danilov p. 906 abstract

Humanization of Murine Monoclonal anti-hTNF Antibody: The F10 Story

G. A. Efimov, J. M. H. Raats, R. G. S. Chirivi, J. W. G. van Rosmalen and S. A. Nedospasov p. 921 abstract

Contents

Molecular Biology